A 48-year-old man with long-standing hypertension, obesity and active smoking has an ASCVD risk of 20% over 10 years. According to NICE lipid modifica...

Question

A 48-year-old man with long-standing hypertension, obesity and active smoking has an ASCVD risk of 20% over 10 years. According to NICE lipid modification guidance, what is the most appropriate primary prevention therapy?

Accepted Answer

Offer Atorvastatin 20 mg once daily.

Answer

Offer lifestyle advice only; statins are reserved for secondary prevention.

Answer

Offer Simvastatin 10 mg once daily.

Answer

Offer Atorvastatin 80 mg once daily.

Answer

Start Ezetimibe monotherapy.

uk-plab-1 MCQ (SBA): Primary prevention of cardiovascular disease

A 48-year-old man with long-standing hypertension, obesity and active smoking has an ASCVD risk of 20% over 10 years. According to NICE lipid modification guidance, what is the most appropriate primary prevention therapy?